The expression rate of PD-L1 in human malignant tumors has been reported to vary from 19% to 92% [8] and the expression of PD-L1 was associated with progression [9-12] and poor prognosis of various human cancers [9,10,13-17]. This evidence concerns the gene CD274 and cancer.